Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> CANADA Latest News

SEP 04, 2013 - Health Canal

A Must Read - Share

No adverse effects in volunteers following Phase I clinical trial of Sumagen AIDS vaccine

Sumagen Canada Inc and Western University announced today that the Phase I Clinical Trial (SAV CT 01) of the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) has been successfully completed with no adverse effects in all patients. Antibody production was also boosted after vaccination.

Tags: No adverse effects in volunteers following Phase I clinical trial of Sumagen AIDS vaccine,  Canada Latest News